0001878894-21-000022.txt : 20211112 0001878894-21-000022.hdr.sgml : 20211112 20211112161853 ACCESSION NUMBER: 0001878894-21-000022 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211110 FILED AS OF DATE: 20211112 DATE AS OF CHANGE: 20211112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Almenoff June Sherie CENTRAL INDEX KEY: 0001492647 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37590 FILM NUMBER: 211403813 MAIL ADDRESS: STREET 1: C/O BRAINSTORM CELL THERAPEUTICS INC. STREET 2: 1325 AVENUE OF AMERICAS 28TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Avalo Therapeutics, Inc. CENTRAL INDEX KEY: 0001534120 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450705648 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 540 GAITHER ROAD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 410-522-8707 MAIL ADDRESS: STREET 1: 540 GAITHER ROAD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: Cerecor Inc. DATE OF NAME CHANGE: 20111102 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2021-11-10 0001534120 Avalo Therapeutics, Inc. AVTX 0001492647 Almenoff June Sherie C/O AVALO THERAPEUTICS, INC. 540 GAITHER ROAD, SUITE 400 ROCKVILLE MD 20850 1 0 0 0 Stock Option (Right to Buy) 2.28 2021-11-10 4 A 0 80000 0 A 2031-11-10 Common Stock 80000 80000 D The stock option will vest in three substantially equal installments on November 10, 2022, November 10, 2023 and November 10, 2024, subject to the Reporting Person's continued service on each such vesting date. /s/ Christopher R. Sullivan, by Power of Attorney 2021-11-12